Evidence map›Paper›PMID 26768709›Full record

ArticleFungal genetics and biology : FG & B2016

Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population.

Massimo Cogliati, Alberto Zani, Volker Rickerts, Ilka McCormick, Marie Desnos-Ollivier, Aristea Velegraki, Patricia Escandon, Tomoe Ichikawa, Reiko Ikeda, Anne-Lise Bienvenu and 6 more

Open access · greenAbstract read
In one paragraph

Article in Fungal genetics and biology : FG & B, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Journal of fungi (Basel, Switzerland) · 2022
    Article
  4. Phenotypic Diversity ofMicroorganisms · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Journal of fungi (Basel, Switzerland) · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in cellular and infection microbiology · 2019
    Article
  15. Frontiers in microbiology · 2019
    Article
  16. Article
  17. Article
  18. The status of cryptococcosis in Latin America.Memorias do Instituto Oswaldo Cruz · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 8 countries.

Massimo CogliatiLab. Micologia Medica, Dip. Scienze Biomediche per la Salute, Università degli Studi di Milano, Milano, Italy. Electronic address: massimo.cogliati@unimi.it.
Alberto ZaniLab. Micologia Medica, Dip. Scienze Biomediche per la Salute, Università degli Studi di Milano, Milano, Italy.
Volker RickertsSection Mycology, Robert-Koch Institute, Berlin, Germany.
Ilka McCormickSection Mycology, Robert-Koch Institute, Berlin, Germany.
Marie Desnos-OllivierUnité de Mycologie Moléculaire, Centre National de Référence Mycoses invasives et Antifongiques, Institut Pasteur, Paris, France.
Aristea VelegrakiDept. of Microbiology, Medical School National and Kapodistrian University of Athens, Athens, Greece.
Patricia EscandonGrupo de Microbiología, Instituto Nacional de Salud, Bogotá, D.C., Colombia.
Tomoe IchikawaDept. of Microbial Science and Host Defense, Meiji Pharmaceutical University, Tokyo, Japan.
Reiko IkedaDept. of Microbial Science and Host Defense, Meiji Pharmaceutical University, Tokyo, Japan.
Anne-Lise BienvenuInstitut de Parasitologie et Mycologie Médicale, Hospices Civils de Lyon, France; Malaria Research Unit, Université de Lyon, Lyon, France.
Kathrin TintelnotSection Mycology, Robert-Koch Institute, Berlin, Germany.
Okan ToreDept. of Medical Microbiology, School of Medicine, Uludag University, Bursa, Turkey.
Sevim AkcaglarDept. of Medical Microbiology, School of Medicine, Uludag University, Bursa, Turkey.
Shawn LockhartAntifungal and Fungal Reference Laboratories, Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Anna Maria TortoranoLab. Micologia Medica, Dip. Scienze Biomediche per la Salute, Università degli Studi di Milano, Milano, Italy.
Ashok VarmaMolecular Microbiology Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Robert Koch Institute · DEUniversity of Milan · ITBursa Uludağ Üni̇versi̇tesi̇ · TRMeiji Pharmaceutical University · JPCenters for Disease Control and Prevention · USInstituto Nacional de Salud · COInstitut Pasteur · FRNational and Kapodistrian University of Athens · GRNational Institute of Allergy and Infectious Diseases · USUniversité Claude Bernard Lyon 1 · FR

Funding

ZINC FINGER-DNA COMPLEXP41RR001646 · NCRR · CORNELL UNIVERSITY ITHACA · PI ROSE, ROBERT C · 1985 to 2011
$23.8M
Intramural NIH HHS Z99 AI999999NCRR NIH HHS P41 RR001646
6 · The paper itself

Abstract

Cryptococcus neoformans var. neoformans (serotype D) represents about 30% of the clinical isolates in Europe and is present less frequently in the other continents. It is the prevalent etiological agent in primary cutaneous cryptococcosis as well as in cryptococcal skin lesions of disseminated cryptococcosis. Very little is known about the genotypic diversity of this Cryptococcus subtype. The aim of this study was to investigate the genotypic diversity among a set of clinical and environmental C. neoformans var. neoformans isolates and to evaluate the relationship between genotypes, geographical origin and clinical manifestations. A total of 83 globally collected C. neoformans var. neoformans isolates from Italy, Germany, France, Belgium, Denmark, Greece, Turkey, Thailand, Japan, Colombia, and the USA, recovered from different sources (primary and secondary cutaneous cryptococcosis, disseminated cryptococcosis, the environment, and animals), were included in the study. All isolates were confirmed to belong to genotype VNIV by molecular typing and they were further investigated by MLST analysis. Maximum likelihood phylogenetic as well as network analysis strongly suggested the existence of a recombinant rather than a clonal population structure. Geographical origin and source of isolation were not correlated with a specific MLST genotype. The comparison with a set of outgroup C. neoformans var. grubii isolates provided clear evidence that the two varieties have different population structures.

Indexed as

Genetic VariationGenotypeMultilocus Sequence TypingMycological Typing TechniquesRecombination, GeneticAmericasAsiaCryptococcosisCryptococcus neoformansEuropePhylogeographyC. neoformans var. grubiiC. neoformans var. neoformansCryptococcusMLSTRecombination

Identifiers

PMID26768709
PMCPMC4754669
OpenAlexW2223345187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.